$CLOV stock is up 11% today. Here's what we see in our data.

$CLOV stock has now risen 11% today, according to our price data from Polygon. There has been approximately $9,176,001 of trading volume.

Here is what we see in our data on $CLOV (you can track the company live on Quiver's $CLOV stock page):

$CLOV Insider Trading Activity

$CLOV insiders have traded $CLOV stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:

BRADY PATRICK PRIEST (CEO of Home Care) sold 175,000 shares for an estimated $379,750
JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 5 sales selling 47,830 shares for an estimated $149,920.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CLOV Hedge Fund Activity

We have seen 83 institutional investors add shares of $CLOV stock to their portfolio, and 97 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

RENAISSANCE TECHNOLOGIES LLC removed 3,221,559 shares (-41.8%) from their portfolio in Q4 2025, for an estimated $7,570,663
DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 2,768,088 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,505,006
BLACKROCK, INC. added 1,885,917 shares (+6.2%) to their portfolio in Q4 2025, for an estimated $4,431,904
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,878,719 shares (-70.7%) from their portfolio in Q4 2025, for an estimated $4,414,989
DIMENSIONAL FUND ADVISORS LP added 1,494,043 shares (+69.8%) to their portfolio in Q4 2025, for an estimated $3,511,001
JANE STREET GROUP, LLC removed 1,380,091 shares (-70.2%) from their portfolio in Q4 2025, for an estimated $3,243,213
GMT CAPITAL CORP removed 1,305,200 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,067,220

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

EARLY ACCESS

Receive CLOV Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CLOV Revenue

$CLOV had revenues of $487.7M in Q4 2025. This is an increase of 44.74% from the same period in the prior year.

You can track CLOV financials on Quiver Quantitative's CLOV stock page.

$CLOV Analyst Ratings

Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Canaccord Genuity issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for $CLOV, check out Quiver Quantitative's $CLOV forecast page.

$CLOV Price Targets

Multiple analysts have issued price targets for $CLOV recently. We have seen 2 analysts offer price targets for $CLOV in the last 6 months, with a median target of $2.85.

Here are some recent targets:

Richard Close from Canaccord Genuity set a target price of $3.2 on 03/20/2026
Whit Mayo from Leerink Partners set a target price of $2.5 on 03/05/2026

You can track data on $CLOV on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.